BMO Capital Markets initiated coverage on Protagonist Therapeutics with a new price target

12/6/24 8:11:17 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

BMO Capital Markets initiated coverage of Protagonist Therapeutics with a rating of Outperform and set a new price target of $62.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PTGX

Date	Price Target	Rating	Analyst
6/17/2025	$72.00	Buy	Citigroup
12/6/2024	$47.00	Neutral	Goldman
12/6/2024	$62.00	Outperform	BMO Capital Markets
11/5/2024	$58.00	Outperform	Wedbush
9/24/2024	$65.00	Buy	TD Cowen
9/9/2024	$60.00	Buy	Truist
10/30/2023	$32.00	Overweight	CapitalOne
5/25/2023	$30.00 → $40.00	Buy	Jefferies